Clinical trials are too slow and too costly—here is how to fix themOur podcast on science and technology. This week, we examine why this mainstay of modern medicine is ailing, and meet the people trying to make it all betterMay 24th 2023CLINICAL TRIALS are the gold standard for testing the safety and efficacy of a treatment or drug, and a keystone in modern medicine.. But their grinding timelines and skyrocketing price tags are hindering development and, ultimately, costing lives…..
https://www.economist.com/clinical-trials-pod?
.For full access to The Economist’s print, digital and audio editions subscribe at economist.com/podcastoffer and sign up for our weekly science newsletter at economist.com/simplyshicience.Listen on: Apple Podcasts | Spotify | Google | Stitcher | TuneInThis podcast by The Economist opens up questions of how to do effective reasonably priced clinical trials
SPL Price at posting:
39.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)